Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 781 AL 795

Cassava food toxins, konzo disease, and neurodegeneration in sub-Sahara Africans

Tshala-Katumbay D, Mumba N, Okitundu L, Kazadi K, Banea M, Tylleskär T, Boivin M, Muyembe-Tamfum JJ.

Neurology. 2013 Mar 5;80(10):949-51. doi: 10.1212/WNL.0b013e3182840b81.

Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair

Marchetti B, L'Episcopo F, Morale MC, Tirolo C, Testa N, Caniglia S, Serapide MF, Pluchino S.

Eur J Neurosci. 2013 May;37(10):1550-63. doi: 10.1111/ejn.12166. Epub 2013 Mar 5.

The beneficial role of thiamine in Parkinson disease

Luong KV, Nguyễn LT.

CNS Neurosci Ther. 2013 Jul;19(7):461-8. doi: 10.1111/cns.12078. Epub 2013 Mar 6.

Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study

Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, Murray A, Counsell C.

Parkinsonism Relat Disord. 2013 May;19(5):515-21. doi: 10.1016/j.parkreldis.2013.01.014. Epub 2013 Feb 23.

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

Siri C, Duerr S, Canesi M, Delazer M, Esselink R, Bloem BR, Gurevich T, Balas M, Giladi N, Santacruz P, Marti F, Tolosa E, Rubino A, Meco G, Poewe W, Pezzoli G, Wenning G, Antonini A.

J Neural Transm (Vienna). 2013 Apr;120(4):613-8. doi: 10.1007/s00702-013-0997-x. Epub 2013 Mar 6.

[Executive function deficits following stroke]

Engstad RT, Engstad TT, Davanger S, Wyller TB.

Tidsskr Nor Laegeforen. 2013 Mar 5;133(5):524-7. doi: 10.4045/tidsskr.12.0686.

Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies

Bisaglia M, Greggio E, Beltramini M, Bubacco L.

FASEB J. 2013 Jun;27(6):2101-10. doi: 10.1096/fj.12-226852. Epub 2013 Mar 5.

Neuroleptic malignant syndrome (parkinsonism-hyperpyrexia syndrome) after deep brain stimulation of the subthalamic nucleus

Urasaki E, Fukudome T, Hirose M, Nakane S, Matsuo H, Yamakawa Y.

J Clin Neurosci. 2013 May;20(5):740-1. doi: 10.1016/j.jocn.2012.04.024. Epub 2013 Mar 5.

The impact of coffee on health

Cano-Marquina A, Tarín JJ, Cano A.

Maturitas. 2013 May;75(1):7-21. doi: 10.1016/j.maturitas.2013.02.002. Epub 2013 Mar 5.

Renal failure in dementia with lewy bodies presenting as catatonia

Fekete R.

Case Rep Neurol. 2013 Jan;5(1):10-3. doi: 10.1159/000346594. Epub 2013 Jan 18.

A systematic review and meta-analysis of measurements of tongue and hand strength and endurance using the Iowa Oral Performance Instrument (IOPI)

Adams V, Mathisen B, Baines S, Lazarus C, Callister R.

Dysphagia. 2013 Sep;28(3):350-69. doi: 10.1007/s00455-013-9451-3. Epub 2013 Mar 7.

Increasing activity in patients with Parkinson's disease

Playford ED.

BMJ. 2013 Mar 6;346:f1429. doi: 10.1136/bmj.f1429.

Mild cognitive impairment in Parkinson's disease: millstone or milestone?

Burn DJ, Barker RA.

Pract Neurol. 2013 Apr;13(2):68-9. doi: 10.1136/practneurol-2013-000539.

Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes

Dobson R, Yarnall A, Noyce AJ, Giovannoni G.

Pract Neurol. 2013 Apr;13(2):70-9. doi: 10.1136/practneurol-2012-000435.

PPAR-γ: therapeutic prospects in Parkinson's disease

Carta AR.

Curr Drug Targets. 2013 Jun;14(7):743-51. doi: 10.2174/1389450111314070004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias